When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Aloe Blacc’s fame means nothing in biotech (and that’s the point)
Originally reported by TechCrunch
Related Articles
Microsoft's new college deal is a half-hearted answer to the $500 MacBook Neo
Apple's MacBook Neo is a $600 (or $500 for students) shot across the bow at affordable Windows laptops, and it seems...
Ford EV and tech chief leaving automaker
Doug Field, the high-profile executive who shaped Ford’s electric vehicle (EV) and technology strategies over the ...
Wait, could they still actually break up Live Nation?
The web of litigation around Live Nation, Ticketmaster, and the companies’ alleged monopoly is getting more compli...
Monarch Tractor’s collapse ends with an acquisition by Caterpillar
Monarch Tractor’s assets have been acquired by construction giant Caterpillar, after struggling to pivot to a soft...